NEWPORT BEACH, Calif., Dec. 3, 2024 /PRNewswire/ — Wave Neuroscience, a leader in personalized non-invasive neuromodulation technology, today announced that its proprietary Magnetic EEG Resonance Therapy (MeRT) system has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for adjunctive treatment of Post-Traumatic Stress Disorder (PTSD).

InnoCare Urologics announced today that it received FDA 510(k) clearance for its novel urinary safety catheter.

Beacon Biosignals announced today that it received FDA authorization for a new update to its Dreem 3S wearable sleep monitoring headband.

FastWave Medical today announced the sixth U.S. utility patent for its laser-based intravascular lithotripsy (IVL) technology for treating calcific artery disease.

Disparities in the accuracy of blood oxygen readings are known to disproportionately affect patients of color, leading to significant health risks because of delayed care.

The new balloon can be expanded before a meal to prevent overeating, then deflated when no longer needed.